The HIFU therapy market is expected to grow significantly soon
due to various factors such as prevalence of chronic diseases such as cancer in
the population, favorable regulatory environment regarding HIFU therapy, and
increase in the aging population globally.
HIFU is a minimally invasive technique that uses focused
ultrasound waves on diseases such as cancer, destroying damaged tissue with
precision and accuracy. Ultrasound waves are focused at a specific location or
focal point. Target tissue at the focal point is destroyed, but tissue outside
the focal point is not damaged.
Explore More Insights@ https://www.alliedmarketresearch.com/request-sample/4698
Europe was the leading revenue contributor to the global
market in 2017, owing to the high adoption rate of HIFU equipment. However,
Asia-Pacific is expected to grow at the highest CAGR of 23.2% from 2018 to 2025
due to rising disposable income; increase in research, development, and
innovation activities; and raising awareness of HIFU therapy equipment.
Top Market Players:
·
Chongqing Haifu Medical Technology Co., Ltd.,
·
EDAP TMS S.A.,
·
SonaCare Medical, LLC.,
·
ILJIN Holdings Co., Ltd. (ALPINION MEDICAL
SYSTEMS Co., Ltd.),
·
Image Guided Therapy S.A.,
·
INSIGHTEC Ltd.,
·
Theraclion SA,
·
Merz Pharmaceuticals GmbH (Ulthera, Inc.),
·
Profound Medical Corp.,
·
Shanghai A&S Technology Development Co.,
Ltd.
0 Comments